IS7528A - Nýir etónógestrel esterar - Google Patents

Nýir etónógestrel esterar

Info

Publication number
IS7528A
IS7528A IS7528A IS7528A IS7528A IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A
Authority
IS
Iceland
Prior art keywords
new
etonogestrel esters
esters
new etonogestrel
etonogestrel
Prior art date
Application number
IS7528A
Other languages
English (en)
Other versions
IS2421B (is
Inventor
De Nijs Henrik
Adrianus Antonius Van Der Voort Hendrikus
Leysen Dirk
Jan Grootenhuis Arij
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of IS7528A publication Critical patent/IS7528A/is
Publication of IS2421B publication Critical patent/IS2421B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7528A 2002-05-30 2004-11-15 Nýir etónógestrel esterar IS2421B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30
PCT/EP2003/050187 WO2003102012A2 (en) 2002-05-30 2003-05-22 New etonogestrel esters

Publications (2)

Publication Number Publication Date
IS7528A true IS7528A (is) 2004-11-15
IS2421B IS2421B (is) 2008-10-15

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7528A IS2421B (is) 2002-05-30 2004-11-15 Nýir etónógestrel esterar

Country Status (31)

Country Link
US (1) US7323454B2 (is)
EP (1) EP1513861B1 (is)
JP (1) JP4716726B2 (is)
KR (1) KR20050009723A (is)
CN (2) CN101100480A (is)
AR (1) AR040130A1 (is)
AT (1) ATE349458T1 (is)
AU (1) AU2003238081B2 (is)
BR (1) BR0311254A (is)
CA (1) CA2487722C (is)
CO (1) CO5631449A2 (is)
DE (1) DE60310714T2 (is)
DK (1) DK1513861T3 (is)
ES (1) ES2277085T3 (is)
HK (1) HK1072609A1 (is)
HR (1) HRP20041101A2 (is)
IL (1) IL165087A0 (is)
IS (1) IS2421B (is)
MX (1) MXPA04011797A (is)
NO (1) NO20044898L (is)
NZ (1) NZ536619A (is)
PE (1) PE20040068A1 (is)
PL (1) PL373855A1 (is)
PT (1) PT1513861E (is)
RS (1) RS97604A (is)
RU (1) RU2325910C2 (is)
SI (1) SI1513861T1 (is)
TW (1) TW200403065A (is)
UA (1) UA80126C2 (is)
WO (1) WO2003102012A2 (is)
ZA (1) ZA200410410B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
US20090062909A1 (en) 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
JP5756588B2 (ja) 2005-07-15 2015-07-29 ミセル テクノロジーズ、インコーポレイテッド 制御されたモルホロジーの薬剤粉末を含むポリマーコーティング
PL2019657T3 (pl) 2006-04-26 2015-10-30 Micell Technologies Inc Powłoki zawierające wiele leków
CN101711137B (zh) 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
JP5608160B2 (ja) 2008-04-17 2014-10-15 ミセル テクノロジーズ、インコーポレイテッド 生体吸収性の層を有するステント
US9486431B2 (en) 2008-07-17 2016-11-08 Micell Technologies, Inc. Drug delivery medical device
WO2011009096A1 (en) 2009-07-16 2011-01-20 Micell Technologies, Inc. Drug delivery medical device
US20100239635A1 (en) 2009-03-23 2010-09-23 Micell Technologies, Inc. Drug delivery medical device
WO2010120552A2 (en) 2009-04-01 2010-10-21 Micell Technologies, Inc. Coated stents
WO2010121187A2 (en) 2009-04-17 2010-10-21 Micell Techologies, Inc. Stents having controlled elution
US11369498B2 (en) 2010-02-02 2022-06-28 MT Acquisition Holdings LLC Stent and stent delivery system with improved deliverability
US10232092B2 (en) 2010-04-22 2019-03-19 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
WO2012009684A2 (en) 2010-07-16 2012-01-19 Micell Technologies, Inc. Drug delivery medical device
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
WO2014165264A1 (en) 2013-03-12 2014-10-09 Micell Technologies, Inc. Bioabsorbable biomedical implants
AU2014265460B2 (en) 2013-05-15 2018-10-18 Micell Technologies, Inc. Bioabsorbable biomedical implants
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
WO1995017896A1 (fr) * 1993-12-27 1995-07-06 Akzo Nobel N.V. Preparation pour absorption par voie percutanee
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
JPH11509222A (ja) * 1995-07-17 1999-08-17 シェリング アクチェンゲゼルシャフト 13−エチル−17β−ヒドロキシ−11−メチレン−18,19−ジノル−17α−プレグン−4−エン−20−イン−3−オンのエステルを含む経皮投与のための剤
WO1999067270A1 (en) 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
CA2333985C (en) 1998-06-19 2007-04-10 Dirk Leysen Testosterone derivative
US6180682B1 (en) 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
NZ536619A (en) 2007-09-28
AU2003238081B2 (en) 2008-09-18
HK1072609A1 (en) 2005-09-02
DK1513861T3 (da) 2007-04-10
MXPA04011797A (es) 2005-03-31
PE20040068A1 (es) 2004-02-18
WO2003102012A9 (en) 2005-01-13
PL373855A1 (en) 2005-09-19
RU2325910C2 (ru) 2008-06-10
EP1513861A2 (en) 2005-03-16
JP4716726B2 (ja) 2011-07-06
CN101100480A (zh) 2008-01-09
RU2004138807A (ru) 2005-05-27
NO20044898L (no) 2005-02-25
AU2003238081A1 (en) 2003-12-19
TW200403065A (en) 2004-03-01
CN1314701C (zh) 2007-05-09
PT1513861E (pt) 2007-03-30
UA80126C2 (en) 2007-08-27
ATE349458T1 (de) 2007-01-15
JP2005532350A (ja) 2005-10-27
KR20050009723A (ko) 2005-01-25
CO5631449A2 (es) 2006-04-28
AR040130A1 (es) 2005-03-16
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
BR0311254A (pt) 2005-03-15
IL165087A0 (en) 2005-12-18
ES2277085T3 (es) 2007-07-01
US20050222113A1 (en) 2005-10-06
IS2421B (is) 2008-10-15
EP1513861B1 (en) 2006-12-27
WO2003102012A2 (en) 2003-12-11
SI1513861T1 (sl) 2007-06-30
ZA200410410B (en) 2006-02-22
DE60310714D1 (de) 2007-02-08
RS97604A (en) 2006-10-27
US7323454B2 (en) 2008-01-29
CN1692122A (zh) 2005-11-02
CA2487722A1 (en) 2003-12-11
HRP20041101A2 (en) 2004-12-31
WO2003102012A3 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
HK1072609A1 (en) New etonogestrel esters
ATE318817T1 (de) Aza-arylpiperazine
ATE427876T1 (de) Luftkissenboot
DE50310866D1 (de) Flanschverbindung
ATA1572002A (de) Managementspleisskassette
NO20034147L (no) Trykkfoleranordning
ATA4142004A (de) Trägerverbau
IS7537A (is) Notkun á nýjum etónógestrel esterum.
ATA19152002A (de) Hubkupplung
DE50214840D1 (de) Ethylestern
ITMI20021327A1 (it) Nuove ossialchilpiperazine
ATE396192T1 (de) N-sulfonylaminothiazole
DE50303658D1 (de) Postgutmessvorrichtung
AT5889U3 (de) Brennholzspleisser
ATA16872002A (de) Zwischenstück
NO20043433L (no) Fremgangsmate
DE50311554D1 (de) Filterhalter
DE50207561D1 (de) Gurthöhenverstellteil
ATA8092002A (de) Pibf
ATA15092002A (de) Beckenräumer
ATA9002003A (de) Luftscaler
ATA5582002A (de) Getränkeerhitzer
DE60219966D1 (de) Virtuelles kegeln
FI5370U1 (fi) Hydrauli-istukka
DE60207974D1 (de) Cyclohexenylcyclopropylketon